Key facts
- Pahtia Technologies’s last known valuation is $1.1M (Mar 2026).
- It has raised $50K.
- Pahtia Technologies has filed 1 Form D with the SEC, most recently Mar 2026 ($45K sold to 5 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Pahtia Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Pahtia Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pahtia Technologies
Developer of a health technology platform designed to increase access to precision medicine for cancer care, particularly for under-researched populations. The company offers genetic analysis and targeted therapy identification using next-generation sequencing and artificial intelligence, enabling healthcare providers and researchers to derive actionable insights and improve treatment decisions.
- Sector
- Healthcare
- HQ
- South Bend, IN, United States
- Founded
- 2024
- Employees
- 8
- Website
- pahtiatech.com/
- Ownership
- Privately Held (backing)
Pahtia Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pahtia Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pahtia Technologies in its N-PORT filings yet. We sweep new filings monthly.